Clinical trial
The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
NCT00451672 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2007
- Completion date
- December 31, 2007
- Enrollment
- 25
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.